Outpatient Facility Coding Alert - 2013 Issue 5
Compliance: OIG Slams Practices for Billing Full Vials of Multi-Use Drugs
Subscribe or sign in to view the full article.
Article Overview
This article reviews an OIG audit and related contractor guidance about billing and documentation practices for drug vials in the Medicare setting. It is aimed at providers, coders, and compliance staff who handle drug administration claims and need to understand the general scope of multi-use versus single-use vial reporting, associated audit concerns, and where official guidance is cited.
Why This Topic Matters
It highlights a common compliance risk area in drug administration billing and shows why accurate documentation and claim reporting matter for avoiding overpayments and audits.
What You Will Learn
- The compliance concerns raised by an OIG audit of drug vial billing
- The general distinction between multi-use and single-use vial claim reporting
- Why documentation and scheduling practices are relevant to medication billing
- What types of official guidance are referenced in the discussion
Who Should Read This
- Medical coders
- Billing staff
- Compliance officers
- Physician practices
- Revenue cycle teams
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com